Showing 51-60 of 229 results for "".
DermWireTV: Diversity in Dermatology; Inclusive Beauty Initiatives; Eczema Awareness Month
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diversity-in-dermatology-inclusive-beauty-initiatives-eczema-awareness-month/20152/La Roche-Posay and the Women's Dermatologic Society have partnered to sponsor a Fellowship in the Department of Dermatology at Howard University's College of Medicine for Underrepresented in medicine medical students. WDS President Mona Gohara, MD shares insights about the need to support DEI in derOral Vitamin D Supplementation and Psoriasis Severity
https://practicaldermatology.com/programs/practical-dermatology/oral-vitamin-d-supplementation-and-psoriasis-severity/24213/In the 2023 study by Jenssen et al. entitled, “Effect of Vitamin D Supplementation on Psoriasis Severity in Patients with Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial,” high-dose oral vitamin D supplementation was not found to have a significant effect on psoriasis severGame On: Learning Gets Upgraded
https://practicaldermatology.com/topics/practice-management/game-on-learning-gets-upgraded/23544/Will gamification change the way dermatologists learn?Triple Threat
https://practicaldermatology.com/topics/general-topics/triple-threat/20629/In defense of the Aron Regimen for resistant atopic dermatitis.Currents: Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/currents-atopic-dermatitis/20353/Smoothing Out Our Understanding of Moisturizers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/smoothing-out-our-understanding-of-moisturizers/20688/New science and new approaches for dry skin.Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/topical-corticosteroids-and-topical-calcineurin-inhibitors-atopic-dermatitis/29118/Analysis of a 2024 study by Gether et al., in which the authors compared the effectiveness of topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) in adults with atopic dermatitis (AD).Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuStaphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.Long-term Management Strategies for AD, Melasma, and More
https://practicaldermatology.com/topics/psoriasis/long-term-management-strategies-for-ad-melasma-and-more/20801/After the acute treatment phase, experts urge a long-view on management.